Inotropes: Intent and Result of Elective Initiation During Heart Failure Hospitalization

Overview

About this study

The purpose of this study is to identify clinical demographics of patients initiated on inotropes during a heart failure admission and observe clinical practice surrounding their use as well as compare whether the perception of treatment duration/outcome of the treating clinicians is different to actual clinical outcomes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients admitted for primary diagnosis of heart failure
Elective (non-shock indication) initiation of inotropes.
Cardiovascular medicine service

Note: Inclusion criteria for physicians for the questionnaire that will be provided to them is that they are the treating physician of a patient enrolled in the study.

Exclusion Criteria:

Admission for planned initiation of inotropes for optimization prior to LVAD implant or cardiac transplantation or UNOS status 1a
Early post-operative (index hospitalization) status
Cardiogenic shock, distributive shock, or obstructive shock
Any patients not fitting the above exclusion criteria considered INTERMACS 1 or 2.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Omar Abou Ezzeddine, M.D., C.M., M.S.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Omar Abou Ezzeddine, M.D., C.M., M.S.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials